Collaborative network analysis for the interpretation of transcriptomics data in rare diseases, an application to Huntington's disease
Ozan ÖzışıkiD, Nazli Sila KaraiD, Tooba Abbassi‐DaloiiiD, Morgane TérézoliD, Núria Queralt-RosiñachiD, Annika JacobseniD, Osman Uğur SezermaniD, Marco RoosiD, Chris T. EveloiD, Anaı̈s BaudotiD, Friederike EhrhartiD, Eleni MinaiD
Abstract
BackgroundRare diseases may affect the quality of life of patients and in some cases be life-threatening. Therapeutic opportunities are often limited, in part because of the lack of understanding of the molecular mechanisms that can cause disease. This can be ascribed to the low prevalence of rare diseases and therefore the lower sample sizes available for research. A way to overcome this is to integrate experimental rare disease data with prior knowledge using network-based methods. Taking this one step further, we hypothesized that combining and analyzing the results from multiple network-based methods could provide data-driven hypotheses of pathogenicity mechanisms from multiple perspectives. ResultsWe analyzed a Huntingtons disease (HD) transcriptomics dataset using six network-based methods in a collaborative way. These methods either inherently reported enriched annotation terms or their results were fed into enrichment analyses. The resulting significantly enriched Reactome pathways were then summarized using the ontological hierarchy which allowed the integration and interpretation of outputs from multiple methods. Among the resulting enriched pathways, there are pathways that have been shown previously to be involved in HD and pathways whose direct contribution to disease pathogenesis remains unclear and requires further investigation. ConclusionsIn summary, our study shows that collaborative network analysis approaches are well-suited to study rare diseases, as they provide hypotheses for pathogenic mechanisms from multiple perspectives. Applying different methods to the same case study can uncover different disease mechanisms that would not be apparent with the application of a single method.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Towards a global investigation of transcriptomic signatures through co-expression networks and pathway knowledge for the identification of disease mechanisms
Rebeca Queiroz Figueiredo, Tamara Raschka, … Daniel Domingo‐Fernándéz·Nucleic Acids ResearchPeer-reviewed·Jun 11, 2021
- Identification of key genes and signaling pathway in the pathogenesis of Huntington's disease via bioinformatics and next generation sequencing data analysis
Basavaraj Mallikarjunayya Vastrad, Chanabasayya Mallikarjunayya Vastrad·Egyptian Journal of Medical Human GeneticsPeer-reviewed·Mar 4, 2025
- A meta-analysis resolves the huntingtin interactome into coactivator losses and a robust proteostatic and synaptic gain network
Manuel Seefelder·bioRxiv·Jul 9, 2026
- Standardized transcriptome analysis improves rare disease diagnosis in the pan-European Solve-RD consortium
Vicente A. Yépez, Rebeka Luknárová, … Julien Gagneur·medRxiv·Feb 14, 2026
- A meta-analysis of transcriptomic profiles from Huntington's disease patients points to a pathophysiological role of CDC42, NFY, DLX1 and PRMT3
Manuel Seefelder, Stefan Kochanek·PLoS ONEPeer-reviewed·Jun 10, 2021
- Identification of Blood Based biomarker for Huntington's disease using in-silico gene expression analysis
Souvik Chakraborty·bioRxiv·Mar 26, 2021